Spiral Therapeutics
Pharmaceutical company developing products for prevention of hearing loss and other inner ear disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD45—68m (Dealroom.co estimates Jan 2023.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $3.0m | Angel | |
| N/A | $1.5m | Seed | |
$3.7m | Series A | ||
* | $8.3m | Early VC | |
* | N/A | Early VC | |
| Total Funding | CAD22.4m | ||
Related Content
Recent News about Spiral Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.